Full text is available at the source.
Abstract
Bariatric surgery typically results in faster and more sustained weight loss compared to pharmacological interventions targeting GLP-1 and GIP receptors.
- Obstructive sleep apnea (OSA) is linked to obesity, which contributes to the condition's severity.
- Limited direct comparisons exist between bariatric surgery and pharmacotherapy for OSA treatment.
- Observational studies indicate that bariatric surgery may lead to better initial improvements in OSA symptoms.
- Pharmacological options may be suitable for patients who are unable to undergo surgical procedures.
- Randomized trials are needed to better define treatment strategies for OSA management.
- A multidisciplinary approach is important for achieving long-term success in treating obesity-related OSA.
Simplified